1-20 of 43
Natalie Callander
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

Clinical Trials & Observations
Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K. Nooka, Salomon Manier, Natalie Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott Solomon, Ingerid Weum Abrahamsen, Rachid Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesús Berdeja, Sergio Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa McKiver, Paula Rodríguez-Otero
Journal: Blood
Blood (2024) 144 (23): 2389–2401.
https://doi.org/10.1182/blood.2024024582
Published: 2024
Includes: Supplemental data
Journal Articles

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 257.
https://doi.org/10.1182/blood-2024-205611
Published: 2024
Journal Articles

Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

Ciara Louise Freeman, Binod Dhakal, Gurbakhash Kaur, Richard T. Maziarz, Natalie Callander, Adam S. Sperling, Carolina Schinke, Andrzej J Jakubowiak, Noa Biran, Douglas W Sborov, Cindy Varga, Abhinav Deol, Abraham S. Kanate, Mehmet Hakan Koçoğlu, Melhem M. Solh, Kamalika Banerjee, Rebecca Chan, Myrna Nahas, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher R. Heery, Tim Welliver, Krina K. Patel, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 1031.
https://doi.org/10.1182/blood-2024-198499
Published: 2024
Journal Articles

MRD-Guided Sequential Therapy for Deep Response in Newly Diagnosed Multiple Myeloma (NDMM)- Master-2 Trial

Binod Dhakal, Rebecca Silbermann, Timothy M Schmidt, Eva Medvedova, Susan Bal, Smith Giri, Naresh Bumma, Abdullah Mohammad Khan, Andrew J. Cowan, Rajshekhar Chakraborty, Gayathri Ravi, Kelly Godby, Bhagirathbhai Dholaria, Muhamed Baljevic, Bria Gendron, Aimaz Afrough, Gurbakhash Kaur, Mary Kwok, Rahul Banerjee, Zhubin Ghavari, Anita D'Souza, Othman S. Akhtar, Meera Mohan, Henning Schade, Ravi Narra, Yubin Kang, Jeffrey V Matous, Larry D Anderson, Jr., Natalie Callander, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 2000.1.
https://doi.org/10.1182/blood-2024-200210
Published: 2024
Journal Articles

Clinical Outcomes in Black Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 Monumental-1 Study

Carolina Schinke, Gareth Morgan, Luciano J. Costa, Natalie Callander, Don A. Stevens, Jesus G Berdeja, Brea Lipe, Sagar Lonial, Marie-Christiane Vekemans, Ravi Vij, Philippe Moreau, Paula Rodríguez-Otero, Anna Sureda Balari, Thomas Renaud, Jaszianne Tolbert, Bonnie W Lau, Brandi W Hilder, Tara J Masterson, Michela Campagna, Veronique Vreys, Christoph Heuck, Colleen Kane, Kathleen S Gray, Deeksha Vishwamitra, Indrajeet Singh, Joy Gong, Xiang Qin, Larysa Sanchez
Journal: Blood
Blood (2024) 144 (Supplement 1): 3357.
https://doi.org/10.1182/blood-2024-199797
Published: 2024
Journal Articles

Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation

Luciano J. Costa, Eva Medvedova, Binod Dhakal, Bhagirathbhai Dholaria, Smith Giri, Saurabh Chhabra, Susan Bal, Kelly Godby, Gayathri Ravi, Rebecca W. Silbermann, Natalie Callander
Journal: Blood
Blood (2024) 144 (Supplement 1): 363.
https://doi.org/10.1182/blood-2024-201914
Published: 2024
Journal Articles

Combination Regimens in MM Post Autologous Hematopoietic Cell Transplantation (AHCT) to Eliminate MRD Utilizing Iberdomide (COMMANDER): Results of Dose-Finding Component of a Phase 1b/2 Trial

Natalie Callander, Gayathri Ravi, Rebecca W. Silbermann, Zhubin J. Gahvari, Eva Medvedova, Bhagirathbhai Dholaria, Naresh Bumma, Doris K. Hansen, Everette M Colquette, Pamela Hardwick, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 3365.
https://doi.org/10.1182/blood-2024-210652
Published: 2024
Journal Articles

Uncovering the Tumor Antigen Landscape in Patients Undergoing Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance Treatment

Dimitra Karagkouni, Giulia Cheloni, Shivani Nanda, Yuling Ma, Shuoshuo Wang, Leda Xanthi Katopodi, Isabella Saldarriaga, Yered Pita-Juarez, David J. Chung, Nina Shah, Natalie Callander, Binod Dhakal, Thinle Chodon, Nikhil C. Munshi, Kenneth C. Anderson, Yvonne A. Efebera, Peiman Hematti, Hillard M. Lazarus, Ehsan Malek, Philip L. McCarthy, Ajay K. Nooka, Krina K. Patel, Aaron P. Rapoport, Robert J. Soiffer, Edmund K. Waller, Marcelo C. Pasquini, Jacalyn Rosenblatt, David Avigan, Ioannis S Vlachos
Journal: Blood
Blood (2024) 144 (Supplement 1): 3289.
https://doi.org/10.1182/blood-2024-211352
Published: 2024
Journal Articles

Efficacy and Safety of Selinexor, Pomalidomide, and Dexamethasone (SPd) for Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Muhamed Baljevic, Nizar J. Bahlis, Rami Kotb, Gary J. Schiller, Brea Lipe, Sumit Madan, Heather J. Sutherland, Suzanne Lentzsch, Natalie Callander, Noa Biran, Dane Van Domelen, Tomer Mark, Darrell White
Journal: Blood
Blood (2024) 144 (Supplement 1): 1996.
https://doi.org/10.1182/blood-2024-208086
Published: 2024
Journal Articles

Quadruplet Induction, Autologous Transplantation and Minimal Residual Disease Adapted Consolidation and Treatment Cessation in Older Adults ≥70y with Newly Diagnosed Multiple Myeloma: A Subgroup Analysis of the Master Trial

Smith Giri, Saurabh Chhabra, Eva Medvedova, Bhagirathbhai Dholaria, Timothy Martin Schmidt, Kelly N. Godby, Rebecca Silbermann, Binod Dhakal, Susan Bal, Anita D'Souza, Aric C. Hall, Pamela Hardwick, Jim Omel, Robert Frank Cornell, Natalie Callander, Parameswaran Hari, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 4431–4433.
https://doi.org/10.1182/blood-2022-160381
Published: 2022
Journal Articles

Genomic and Transcriptional Profiling Stratifies Vq Myeloma Lines into Two Clusters with Distinct Risk Signatures and Drug Responses

Evan Flietner, Mei Yu, Adhithi Rajagopalan, Yun Zhou, Yubin Feng, Anthony Veltri, Terra Lasho, Zhi Wen, Yuqian Sun, Robert Burns, Mrinal M. Patnaik, Natalie Callander, Fotis Asimakopoulos, Demin Wang, Jing Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9935–9936.
https://doi.org/10.1182/blood-2022-162827
Published: 2022
Journal Articles

Single-Agent Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma: Final Analysis of the DREAMM-2 Trial

Ajay K. Nooka, Adam Cohen, Hans C. Lee, Ashraf Z. Badros, Attaya Suvannasankha, Natalie Callander, Al-Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward Libby, Maria Chaudhry, Malin Hultcrantz, Martin Kortuem, Paul G. Richardson, Rakesh Popat, Douglas W. Sborov, Shawn Hakim, Eric Lewis, Bharat Bhushan, Boris Gorsh, Ira Gupta, Joanna Opalinska, Sagar Lonial
Journal: Blood
Blood (2022) 140 (Supplement 1): 7301–7303.
https://doi.org/10.1182/blood-2022-164877
Published: 2022
Journal Articles

Once Weekly Selinexor, Carfilzomib and Dexamethasone (XKd) in Triple Class Refractory Multiple Myeloma

Gary J. Schiller, Sascha A. Tuchman, Natalie Callander, Muhamed Baljevic, Adrianna C Rossi, Rami Kotb, Darrell J White, Nizar J. Bahlis, Heather J. Sutherland, Sumit Madan, Richard Leblanc, Christopher P. Venner, William I. Bensinger, Dane R. Van Domelen, Chris Zhang, Ohad S. Bentur, Brea Lipe
Journal: Blood
Blood (2022) 140 (Supplement 1): 10050–10053.
https://doi.org/10.1182/blood-2022-158011
Published: 2022
Journal Articles

Optimal Sequencing Determination in Relapsed Multiple Myeloma

Salyka M. Sengsayadeth, Bridget Fitzgerald, Bharat Nandakumar, Bicky Thapa, Timothy Martin Schmidt, Rebecca Silbermann, Heidi Chen, Saurabh Chhabra, Natalie Callander, Shaji K Kumar, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 10033–10035.
https://doi.org/10.1182/blood-2022-169589
Published: 2022
Journal Articles

Outcomes of MRD-Adapted Treatment Modulation in Patients with Newly Diagnosed Multiple Myeloma Receiving Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) and Autologous Transplantation: Extended Follow up of the Master Trial

Luciano J. Costa, Saurabh Chhabra, Eva Medvedova, Timothy Martin Schmidt, Bhagirathbhai Dholaria, Kelly N. Godby, Rebecca Silbermann, Susan Bal, Anita D'Souza, Smith Giri, James L. Omel, Parameswaran Hari, Natalie Callander, Binod Dhakal
Journal: Blood
Blood (2022) 140 (Supplement 1): 7275–7277.
https://doi.org/10.1182/blood-2022-156730
Published: 2022
Journal Articles

Analysis of Transplant-Eligible Patients (Pts) Who Received Frontline Daratumumab (DARA)-Based Quadruplet Therapy for the Treatment of Newly Diagnosed Multiple Myeloma (NDMM) with High-Risk Cytogenetic Abnormalities (HRCA) in the Griffin and Master Studies

Natalie Callander, Rebecca Silbermann, Jonathan L. Kaufman, Kelly N. Godby, Jacob P Laubach, Timothy Martin Schmidt, Douglas W Sborov, Eva Medvedova, Brandi Reeves, Binod Dhakal, Cesar Rodriguez, Saurabh Chhabra, Ajai Chari, Susan Bal, Larry D. Anderson, Jr., Bhagirathbhai Dholaria, Nitya Nathwani, Parameswaran Hari, Nina Shah, Naresh Bumma, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Ken H. Shain, Andrew J. Cowan, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S. Lin, Smith Giri, Luciano J. Costa, Paul G. Richardson, Saad Usmani, Peter M. Voorhees
Journal: Blood
Blood (2022) 140 (Supplement 1): 10144–10147.
https://doi.org/10.1182/blood-2022-160451
Published: 2022
Journal Articles

Humoral Immune Reconstitution Following Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd), Autologous Hematopoietic Cell Transplantation (AHCT) and MRD-Response-Adapted Treatment Cessation

Timothy Martin Schmidt, Rebecca Silbermann, Susan Bal, Binod Dhakal, Bhagirathbhai Dholaria, Eden Biltibo, Saurabh Chhabra, Smith Giri, Kelly N. Godby, Sonia Gowda, Eva Medvedova, Natalie Callander, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 10077–10078.
https://doi.org/10.1182/blood-2022-164930
Published: 2022
Journal Articles

IV Antibiotic Use during Autologous Hematopoietic Stem Cell Transplantation Is Associated with Inferior Survival in Patients with Multiple Myeloma

Matthew Gromowsky, Zhubin Gahvari, Robin High, Natalie Callander, Christopher D'Angelo
Journal: Blood
Blood (2022) 140 (Supplement 1): 7716–7717.
https://doi.org/10.1182/blood-2022-163359
Published: 2022
Journal Articles

Immunoregulatory roles of versican proteolysis in the myeloma microenvironment

Brief Report
Chelsea Hope, Simon Foulcer, Justin Jagodinsky, Sarah X. Chen, Jeffrey L. Jensen, Sanjay Patel, Catherine Leith, Ioanna Maroulakou, Natalie Callander, Shigeki Miyamoto, Peiman Hematti, Suneel S. Apte, Fotis Asimakopoulos
Journal: Blood
Blood (2016) 128 (5): 680–685.
https://doi.org/10.1182/blood-2016-03-705780
Published: 2016
Includes: Supplemental data
Journal Articles

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Clinical Trials & Observations
Shaji K. Kumar, Betsy LaPlant, Wee Joo Chng, Jeffrey Zonder, Natalie Callander, Rafael Fonseca, Briant Fruth, Vivek Roy, Charles Erlichman, A. Keith Stewart
Journal: Blood
Blood (2015) 125 (3): 443–448.
https://doi.org/10.1182/blood-2014-05-573741
Published: 2015